妇科手术后阿片类药物处方与患者使用情况:患者与提供者调查
该调查纳入波士顿地区96名妇科医生和2015年1月至2016年4月间147名良性子宫切除术患者,分别调查处方习惯与阿片类药物消耗。医生在腹式子宫切除术后平均处方27.1片,显著多于腹腔镜(22.6片)和阴式(16.8片);患者调查显示多数患者使用不足处方量的一半,部分完全未用。
要点
- 医生腹式子宫切除术后阿片处方量显著高于腹腔镜和阴式子宫切除术。
- 64.6%患者使用不足处方量的一半,16.1%完全未使用阿片类药物。
- 不同子宫切除途径间患者阿片消耗量无显著差异。
核心结论
- 医生阿片处方习惯差异大,患者术后阿片消耗量普遍低于处方量。
- 微创子宫切除术后医生处方阿片片数少于开腹子宫切除术。
- 多数患者使用不足处方量的一半,部分患者完全未使用。
研究设计与样本
- 调查研究(加拿大任务force分类III级),包括医生在线调查和患者电话调查。
- 设置:城市学术三级护理医院。
- 对象:波士顿地区96名妇科医生和2015年1月至2016年4月间行良性子宫切除术的147名患者。
- 医生调查:通过电子邮件联系参与在线调查;患者调查:通过电话联系参与电话调查。
主要发现
- 51名医生回应在线调查,腹式子宫切除术后平均处方27.1片(范围5-30)羟考酮(5 mg)或氢吗啡酮(2 mg)。
- 腹腔镜子宫切除术后平均处方22.6片(范围5-30),阴式子宫切除术后平均处方16.8片(范围5-30)。
- 腹式与腹腔镜子宫切除处方量平均差4.5片(标准差4.7;p < .01),腹式与阴式平均差6.8片(标准差5.8;p < .01),均统计学显著。
- 40.0%医生在宫腔镜后处方阿片,19.2%在刮宫后处方。
- 56名患者参与电话调查:64.6%使用不足处方量一半,16.1%未使用。
关键数值与推荐
- 腹式子宫切除:患者报告平均处方25.7片,平均使用8.7片(范围0-60;使用率33.9%)。
- 腹腔镜或阴式子宫切除:患者报告平均处方24.2片,平均使用10.0片(范围0-30;使用率41.4%)。
- 患者阿片消耗腹式与腹腔镜比较p = .613,腹式与阴式比较p = .279,无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To describe opioid distribution and patient use after gynecologic procedures. DESIGN: Survey study (Canadian Task Force classification III). SETTING: An urban academic tertiary care hospital. SUBJECTS: Ninety-six gynecologists in the Boston area, and 147 patients who underwent a benign hysterectomy between January 2015 and April 2016. INTERVENTIONS: Survey study of physicians and patients composed of 2 parts: (1) a physician survey on opioid prescribing practices after gynecologic procedures and (2) a patient survey on opioid consumption after hysterectomy. Physicians were contacted via e-mail to participate in an online survey. Eligible patients were contacted via telephone and asked to participate in a telephone survey. MEASUREMENTS AND MAIN RESULTS: Fifty-one physicians responded to an online survey and prescribed a mean of 27.1 tablets (range, 5-30) of oxycodone (5 mg) or hydromorphone (2 mg) after abdominal hysterectomy (AH), a mean of 22.6 tablets (range, 5-30) after laparoscopic hysterectomy (LH), and a mean of 16.8 tablets (range 5-30) after vaginal hysterectomy (VH). Physicians prescribed more opioids for AH compared with LH, with a mean difference of 4.5 tablets (standard deviation, 4.7; p < .01), and AH compared with VH, with a mean difference of 6.8 tablets (standard deviation, 5.8; p < .01), which were both statistically significant. In addition, 40.0% of physicians prescribe opioids after a hysteroscopy and 19.2% after a dilation and curettage. Fifty-six patients participated in the telephone survey: 64.6% of patients used less than half of the opioids prescribed and 16.1% used none. For AH, patients reported being prescribed a mean of 25.7 tablets and using a mean of 8.7 tablets (range, 0-60; 33.9% used). For LH or VH, patients reported being prescribed a mean of 24.2 tablets and using a mean of 10.0 tablets (range, 0-30; 41.4% used). Opioid consumption was not significantly different for AH compared with LH or VH (p = .613 for AH to LH, p = .279 for AH to VH). CONCLUSIONS: With respect to the physician survey, we conclude there is a wide range of opioid prescription practices and patient opioid consumption after gynecologic surgery. The patient survey revealed that physicians prescribe fewer opioid tablets after a minimally invasive approach to hysterectomy versus open hysterectomy. However, most patients use less than half of prescribed opioids, and a fraction did not use any opioids at all.
引用
- Griffith KC, Clark NV, Zuckerman AL, et al. Opioid Prescription and Patient Use After Gynecologic Procedures: A Survey of Patients and Providers. J Minim Invasive Gynecol. 2017. PMID: 29154933. doi:10.1016/j.jmig.2017.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。